Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults

References

• Watson T, Mock V. Exercise as an intervention for cancer-related fatigue. Phys Ther 2004; 84: 736–743
   PubMed Web of Science ®Google Scholar
• Mock V. Evidence-based treatment for cancer related fatigue. J Natl Cancer Inst Monogr 2004; 32: 112–118
   PubMedGoogle Scholar
• Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet 2003; 362: 640–650
   PubMed Web of Science ®Google Scholar
• Lawrence D P, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr 2004; 32: 40–50
   PubMedGoogle Scholar
• Hogarty A N, Silber J H, Paridon S M. Cardiopulmonary exercise testing in evaluation of the functional capacity of survivors of childhood cancer. Prog Pediatr Cardiol 1998; 8: 109–119
   Google Scholar
• Black P, Gutjahr P, Stopfkuchen H. Physical performance in long-term survivors of acute leukaemia in childhood. Eur J Pediatr 1998; 157: 464–467
   PubMed Web of Science ®Google Scholar
• Messori A, Vaiani M, Trippoli S. Survival in patients with intermediate or high-grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP. Br J Cancer 2001; 84: 303–307
   PubMed Web of Science ®Google Scholar
• Lister T A, Crowther D, Sutcliffe S B, Glatstein E, Canellos G P, Young R C, et al. Report of a committee convened to discuss the evaluaiton and staging of patients with Hodgkin's disease: Costwolds meeting. J Clin Oncol 1989; 7: 1630–1636
   PubMed Web of Science ®Google Scholar
• Glossmann J P, Josting A, Diehl V. New treatments for Hodgkin's disease. Curr Treat Options Oncol 2002; 3: 283–290
   PubMedGoogle Scholar
• Otto C M. Echocardiographic evaluation of left and right ventricular systolic function. Textbook of Clinical Echocardiography, 2nd edn, C M Otto. WB Saunders, Philadelphia, PA 2000; 100–131
   Google Scholar
• Otto C M. Echocardiographic evaluation of ventricular diastolic filling and function. Textbook of Clinical Echocardiography, 2nd edn, C M Otto. WB Saunders, Philadelphia, PA 2000; 132–153
   Google Scholar
• Beck K C, Weisman I M. Methods for cardiopulmonary exercise testing. Clinical Exercise Testing, I M Weisman, R J Zeballos. Progress in Respiratory Research, Basel, Karger 2002; 43–59
   Google Scholar
• Picano E. Stress Echocardiography, 3rd edn. Springer-Verlag, Berlin 1997; 1–305
   Google Scholar
• Wu H S, McSweeney M. Assessing fatigue in persons with cancer. Cancer 2004; 101: 1685–1695
   PubMed Web of Science ®Google Scholar
• Ruffer J U, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, et al. Fatigue in long-term survivors of Hodgkin's lymphoma: a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer 2003; 39: 2179–2186
   PubMed Web of Science ®Google Scholar
• Wagner L, Cella D. Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 2004; 91: 822–828
   PubMed Web of Science ®Google Scholar
• Lund M B, Kongerud J, Boe J, Nome O, Abrahamsen A F, Ihlen H, Forfang K. Cardiopulmonary sequelae after treatment for Hodgkin's disease: increased risk in females?. Annals Oncol 1996; 7: 257–264
   PubMed Web of Science ®Google Scholar
• Villani F, Catania A F, Laffranchi A, Maffioli L, Viviani S, Bonfante V. Effect of an intensive chemotherapy followed by mediatinal irradiation on pulmonary and cardiac function in advanced Hodgkin's disease. Cancer Invest 2003; 21: 185–192
   PubMed Web of Science ®Google Scholar
• Green D M, Gingell R L, Pearce J, Panahon A M, Ghoorah J. The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 1987; 5: 239–245
   PubMed Web of Science ®Google Scholar
• Hancock S L, Tucker M A, Hoppe R T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993; 27: 1949–1955
   Google Scholar
• Quigg R J. Clinical utility of cardiopulmonary exercise testing data in heart failure. Exercise and Heart Failure, 1st edn, G J Balady, I L Pina. Futura Publishing Company, Inc, New York 1997; 221–243
   Google Scholar
• Hogarthy A N, Silber J H, Paridon S M. Cardiopulmonary exercise testing in evaluation of the functional capacity of survivors of childhood cancer. Progr Pediatr Cardiol 1998; 8: 109–119
   Google Scholar
• Hauser M, Gibson B S, Wilson N. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress echocardiography. Eur J Pediatr 2001; 160: 607–610
   PubMed Web of Science ®Google Scholar
• Johnson D, Perrault H, Fournier A, Leclerc J M, Bigras J L, Davignon A. Cardiovascular responses to dynamic submaximal exercise in children previously treated with anthracycline. Am Heart J 1997; 133: 169–173
   PubMed Web of Science ®Google Scholar
• Black P, Gutjahr P, Stopfkuchen. Physical performance in long-term survivors of acute leukaemia in childhood. Eur J Pediatr 1998; 157: 464–467
   PubMed Web of Science ®Google Scholar
• Maeda A, Honda M, Kuramochi T, Takbatake T. Doxorubicin cardiotoxicity. Diastolic cardiac myocyte dysfunction as a result of impaired calcium handling in isolated cardiac myocytes. Jpn Circ J 1998; 62: 505–511
   PubMedGoogle Scholar
• Lee B H, Goodenday L S, Muswick G J, Yasnoff W A, Leighton R F, Skeel R T. Alteration in left ventricular diastolic function with doxorubicin therapy. J Am Coll Cardiol 1987; 9: 184–188
   PubMed Web of Science ®Google Scholar
• Stoddard M F, Seeger J, Liddell N E, Hadley T J, Sullivan D M, Kupersmith J. Prolongation of isovolumetric relaxation time as assessed Doppler echocardiography predicts doxorubicin-induced systolic dysfunction in humans. J Am Coll Cardiol 1992; 20: 62–69
   PubMed Web of Science ®Google Scholar
• Litwin S E, Grossman W. Diastolic dysfunction as a cause of heart failure. J Am Coll Cardiol 1993; 22: 49A–55A
   PubMed Web of Science ®Google Scholar
• Genovesi-Ebert A, Marabotti C, Palombo C, Giacono S, Rossi G, Ghione S. Echo Doppler diastolic function and exercise tolerance. Int J Cardiol 1994; 43: 67–73
   PubMed Web of Science ®Google Scholar
• Parthenakis F I, Kanoupakis E M, Kochiadakis G E, Skalidis E I, Mezelis N E, Simantirakis E N, et al. Left ventricular diastolic filling pattern predicts cardiopulmonary determinants of functional capacity in patients with congestive heart failure. Am Heart J 2000; 140: 338–344
   PubMed Web of Science ®Google Scholar
• Links M, Lewis C. Chemoprotectans. A review of their clinical pharmacology and their efficacy. Drugs 1999; 57: 293–308
   PubMed Web of Science ®Google Scholar
• Schuchter L M, Hensley M L, Meropol N J, Winer E P. 2002 Update of recommendations for the use of chemotherapy and radiotherapy protectans: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2002; 20: 2895–2903
   PubMed Web of Science ®Google Scholar
• Belardinelli R, Georgiou D, Cianci G, Berman N, Ginzton L, Purcaro A. Exercise training improves left ventricular diastolic filling in patients with dilated cardiomyopathy. Circulation 1995; 91: 2775–2784
   PubMed Web of Science ®Google Scholar
• Sullivan M J, Duscha B D. Cardiovascular adaptations to exercise training in left ventricular dysfunction. Exercise and Heart Failure, 1st edn, G J Balady, I L Pina. Futura Publishing Company, Inc, New York 1997; 261–277
   Google Scholar